Levamisol CAS: 14769-73-4

CAS NO: 14769-73-4
Levamisol
Chemical Name: Levamisole
Molecular Formula: C11H12N2S
Formula Weight: 204.29
CAS No.: 14769-73-4
Description Review
Description

Levamisole, also known as levamisol, is a broad-spectrum anthelmintic. It is a synthetic imidazothiazole derivative that was first developed in the 1960s. Levamisole has been used to treat a variety of parasitic infections in humans and animals. It is also used as an immunomodulator in the treatment of certain autoimmune diseases.

Chemical name:

The chemical name for Levamisole is (S)-2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole.

Molecular formula:

The molecular formula for Levamisole is C11H12N2S.

Formula weight:

The formula weight for Levamisole is 204.29 g/mol.

CAS No:

The CAS number for Levamisole is 14769-73-4.

Top ten keywords from Google and synonyms:

  1. Anthelmintic
  2. Immunomodulator
  3. Parasitic infections
  4. Autoimmune diseases
  5. Dewormer
  6. Levamisol hydrochloride
  7. Levamisole HCl
  8. Veterinary medicine
  9. Immune system
  10. Side effects

Synonyms:

  • Ergamisol
  • Levasole
  • Tramisol
  • Solaskil
  • Neguvon

Health benefits of Levamisole:

Levamisole is primarily used to treat parasitic infections such as roundworms, hookworms, and pinworms. It works by paralyzing the worms' muscles and inhibiting their nervous systems, ultimately leading to their death. Additionally, levamisole has been shown to have immunomodulatory properties. It helps to stimulate the immune system, making it more effective at fighting off infections and diseases.

Potential effects:

In addition to its use as an anthelmintic and immunomodulator, levamisole has shown promise in treating certain types of cancer. It has been shown to inhibit tumor growth and increase the effectiveness of other cancer treatments such as chemotherapy. Levamisole has also been used in veterinary medicine to treat parasitic infections in livestock.

Product mechanism:

Levamisole works by interfering with the worms' nervous systems and paralyzing their muscles. This ultimately leads to their death and expulsion from the body. The immunomodulatory effects of levamisole are not fully understood but are thought to involve stimulation of T-lymphocytes and other immune cells.

Safety:

Levamisole is generally considered safe when used as directed. However, it can cause side effects in some people, particularly at higher doses. Levamisole should not be used in individuals with a history of allergy or hypersensitivity to the drug. It may also interact with certain medications, so it is important to inform your doctor of all medications you are taking before using levamisole.

Side effects:

Common side effects of levamisole include nausea, vomiting, diarrhea, and abdominal pain. Less commonly, it may cause dizziness, headache, fatigue, or skin rash. In rare cases, levamisole has been associated with more serious side effects such as agranulocytosis (a condition where the body does not produce enough white blood cells) and vasculitis (inflammation of blood vessels).

Dosing information:

The dosing regimen for levamisole will depend on the specific condition being treated and the age and weight of the individual. Levamisole is available in various forms, including tablets, oral suspension, and injectable solution. It is important to follow the dosing instructions provided by your doctor or pharmacist carefully.

Conclusion:

Levamisole is a broad-spectrum anthelmintic and immunomodulator that has been used for several decades to treat parasitic infections in humans and animals. It has also shown promise in treating certain types of cancer and has been used in veterinary medicine to treat parasitic infections in livestock. Although generally considered safe, levamisole can cause side effects and may interact with certain medications. As with any medication, it is important to use levamisole only as directed and under the supervision of a healthcare provider.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code